Medtech Commercialization

Cold Plasma Healthcare Market to Hit $6.6B by 2032, Growing 12.7%

Image
Cold Plasma Healthcare Market to Hit $6.6B by 2032, Growing 12.7%

London – – October 08, 2026 -- The global cold plasma in healthcare market is projected to climb from $2,873 million in 2025 to $6,634 million by 2032, a compound annual growth rate of 12.7%, according to a new report from Credence Research Inc.

Devices dominate revenue while consumables build recurring streams

Devices accounted for 68.4% of product-segment revenue in 2025, reflecting continued emphasis on installed treatment capacity ahead of scaling consumables and service income. Plasma Jet technology held 39.6% of the technology segment, while Atmospheric Pressure Cold Plasma captured 66.8% of the pressure-type category, favored for bedside and outpatient use without vacuum infrastructure.

SciBase Secures SEK 57.5M as Rights Issue Fully Subscribed

Stockholm – October 01, 2026 -- SciBase Holding AB has closed its rights issue fully subscribed, raising approximately SEK 57.5 million before issue costs to fund continued commercialisation of its Nevisense melanoma-diagnostics platform in the United States.

Shareholders cover nearly three-quarters of the offering

The subscription period, which ran through 29 September 2026, saw 2,681,085 shares subscribed with the support of subscription rights, equal to roughly SEK 40.2 million, or 69.9 percent of the issue. An additional 133,116 shares were subscribed without subscription rights, adding SEK 2.0 million, or 3.5 percent. In total, 2,814,201 shares were subscribed with and without rights, covering approximately SEK 42.2 million, or 73.4 percent of the SEK 57.5 million target.